| scholarly article | Q13442814 |
| P2093 | author name string | Camm AJ | |
| Patel P | |||
| Levy J | |||
| Strachan DP | |||
| Leatham E | |||
| Carrington D | |||
| Mendall MA | |||
| Seymour CA | |||
| Blakeston C | |||
| Molineaux N | |||
| P2860 | cites work | Dental disease, fibrinogen and white cell count; links with myocardial infarction? | Q57403400 |
| Procoagulant activity expression by macrophages from atheromatous vascular plaques | Q69403253 | ||
| Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study | Q69886150 | ||
| Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation | Q70548074 | ||
| Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis | Q72209255 | ||
| [Rapid physiological coagulation method in determination of fibrinogen] | Q74515389 | ||
| Association between dental health and acute myocardial infarction | Q24675367 | ||
| Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection | Q35095122 | ||
| Serum sialic acid concentration and cardiovascular mortality | Q35178190 | ||
| Prevalence of ischaemic heart disease in middle aged British men. | Q36750075 | ||
| The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. | Q36913978 | ||
| Early life experience and adult cardiovascular disease: longitudinal and case-control studies | Q37001298 | ||
| Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. | Q37132394 | ||
| : Risk factors for seropositivity and association with coronary heart disease | Q37887420 | ||
| Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries | Q37891287 | ||
| Association of Prior Infection With Chlamydia pneumoniae and Angiographically Demonstrated Coronary Artery Disease | Q37892814 | ||
| Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study | Q37893723 | ||
| Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction | Q37899465 | ||
| Human serology in Chlamydia trachomatis infection with microimmunofluorescence | Q37912807 | ||
| Helicobacter pylori and the heart | Q39025542 | ||
| Childhood living conditions and Helicobacter pylori seropositivity in adult life | Q41089349 | ||
| Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study | Q41206667 | ||
| Relation of Helicobacter pylori infection and coronary heart disease | Q41333642 | ||
| Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis | Q41878177 | ||
| Fibrinogen: a link between chronic infection and coronary heart disease | Q43433246 | ||
| Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies | Q43950275 | ||
| P433 | issue | 7007 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circulatory system | Q11068 |
| Helicobacter pylori | Q180556 | ||
| heart disease | Q190805 | ||
| Helicobacter pylori infectious disease | Q4497153 | ||
| coronary artery disease | Q844935 | ||
| Chlamydia pneumoniae | Q62869737 | ||
| P304 | page(s) | 711-714 | |
| P577 | publication date | 1995-09-01 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors | |
| P478 | volume | 311 |
| Q35203718 | A high sensitivity assay is more accurate than a classical assay for the measurement of plasma CRP levels in endometriosis |
| Q36899153 | A review of the postulated mechanisms concerning the association of Helicobacter pylori with ischemic heart disease |
| Q46831663 | A study of arteriosclerosis in healthy subjects with HBV and HCV infection |
| Q54013888 | Acute-phase inflammatory response to periodontal disease in the US population. |
| Q44674777 | Another cause of hyperhomocysteinemia |
| Q33588514 | Antibiotics for myocardial infarction? A possible role of infection in atherogenesis and acute coronary syndromes |
| Q24201388 | Antibiotics for secondary prevention of coronary heart disease |
| Q37874993 | Antibodies to Chlamydia pneumoniae and clinical course in patients with unstable angina pectoris |
| Q36348895 | Are modern environments really bad for us?: revisiting the demographic and epidemiologic transitions |
| Q37872597 | Association analysis of polymorphisms at the interleukin-1 locus in essential hypertension |
| Q36114202 | Association between Helicobacter pylori Infection and Cerebral Small Vessel Disease |
| Q44770826 | Association between alveolar bone loss and elevated serum C-reactive protein in Japanese men. |
| Q44088443 | Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus |
| Q47137014 | Association of Helicobacter Pylori with Presence of Myocardial Infarction in Iran: A Systematic Review and Meta-Analysis. |
| Q43186591 | Association of Helicobacter pylori infection with coronary heart disease. Association may not be causal |
| Q42877883 | Association of Helicobacter pylori infection with coronary heart disease. Eradication of the infection on grounds of cardiovascular risk is not supported by current evidence |
| Q43186543 | Association of Helicobacter pylori infection with coronary heart disease. Study confirms previous findings. |
| Q43186529 | Association of Helicobacter pylori infection with coronary heart disease. Study shows association between H pylori infection and hypertension |
| Q77910810 | Association of Helicobacter pylori infection with elevated serum lipids |
| Q50566741 | Association of Helicobacter pylori infection with lifestyle, chronic disease, body-indices, and age at menarche in Danish adults. |
| Q71620480 | Association of Helicobacter pylori infection with primary Raynaud phenomenon |
| Q73763016 | Association of elevation of anti-Helicobacter pylori antibody with myocardial ischemic events in coronary artery disease |
| Q73250259 | Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study |
| Q35413402 | Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status |
| Q36082394 | Atrophic gastritis is associated with coronary artery disease |
| Q71214901 | Blood leukocyte differential in Helicobacter pylori infection |
| Q48088880 | C-reactive protein (CRP) in cerebro-vascular events |
| Q74694137 | C-reactive protein and multiple complex coronary artery plaques in patients with primary unstable angina |
| Q73127397 | C-reactive protein and the risk of cardiovascular mortality |
| Q31113902 | C-reactive protein as a marker for active coronary artery disease in patients with chest pain in the emergency room. |
| Q37873310 | C-reactive protein is increased in patients with degenerative aortic valvular stenosis |
| Q37877470 | Can an antibiotic (macrolide) prevent Chlamydia pneumoniae-induced atherosclerosis in a rabbit model? |
| Q44228420 | Can the premises of the altered homeostatic theory permit improvement in the prevention of ischemic heart disease? |
| Q37477948 | Cardiac complication after experimental human malaria infection: a case report |
| Q43967362 | Cardiovascular risk factors in subjects with Helicobacter pylori infection |
| Q35558187 | Childhood leg length and adult mortality: follow up of the Carnegie (Boyd Orr) Survey of Diet and Health in Pre-war Britain |
| Q57114252 | Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogen |
| Q37867438 | Chlamydia pneumoniae DNA is more frequent in advanced than in mild atherosclerosis lesions |
| Q33534714 | Chlamydia pneumoniae and atherosclerosis. |
| Q33659387 | Chlamydia pneumoniae and coronary heart disease |
| Q37849596 | Chlamydia pneumoniae and helicobacter pylori serology - importance in patients with coronary heart disease |
| Q37880177 | Chlamydia pneumoniae and vascular disease |
| Q35370873 | Chlamydia pneumoniae antibodies are associated with an atherogenic lipid profile |
| Q37881662 | Chlamydia pneumoniae antibody response in patients with acute myocardial infarction and their follow-up |
| Q37228857 | Chlamydia pneumoniae in atheroma: consideration of criteria for causality |
| Q37878342 | Chlamydia pneumoniae infection and atherosclerotic coronary disease |
| Q37873843 | Chlamydia pneumoniae infection and its association with coronary heart disease and cardiovascular risk factors in a sample South Asian population |
| Q37876040 | Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective study |
| Q37867152 | Chlamydia pneumoniae infection in young stroke patients: a case--control study |
| Q35559048 | Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. |
| Q33972282 | Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals |
| Q37866396 | Chlamydia pneumoniae seropositivity and cardiovascular risk factors: The InCHIANTI Study. |
| Q37878309 | Chlamydia pneumoniae-reactive T lymphocytes in abdominal aortic aneurysms: the smoking gun? |
| Q37851604 | Chlamydophila pneumoniae antibodies may be independently associated with increased BMI and percentage of body fat among women |
| Q37870867 | Chronic Chlamydia pneumoniae infection in patients with coronary disease. Relation with increased fibrinogen values |
| Q43761516 | Chronic Helicobacter pylori infection and ischemic stroke subtypes |
| Q33843633 | Chronic infection and coronary artery disease |
| Q79299394 | Chronic infection and coronary artery disease |
| Q33596962 | Chronic infection in the aetiology of atherosclerosis--focus on Chlamydia pneumoniae |
| Q37882065 | Chronic infection in the etiology of atherosclerosis--the case for Chlamydia pneumoniae |
| Q35371043 | Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: population based study of coronary heart disease |
| Q37882245 | Chronic infections and coronary heart disease: is there a link? |
| Q37862624 | Chronic peripheral arteriopathy is associated with seropositivity to Chlamydia pneumoniae |
| Q55033532 | Cinnamon extracts' inhibitory effect on Helicobacter pylori. |
| Q37877457 | Circulating Chlamydia pneumoniae DNA as a predictor of coronary artery disease |
| Q40995330 | Clinical expressions of Helicobacter pylori infection. |
| Q38211000 | Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence. |
| Q54104957 | Colonic bacterial activity and serum lipid risk factors for cardiovascular disease. |
| Q52631048 | Comprehensive analysis of Helicobacter pylori infection-associated diseases based on miRNA-mRNA interaction network. |
| Q35129733 | Constipation and risk of cardiovascular disease among postmenopausal women |
| Q47304233 | Contemporary work characteristics, stress, and ill health |
| Q44897698 | Coronary artery disease associated with Helicobacter pylori infection is at least partially due to inadequate folate status |
| Q43650993 | Correlation between Helicobacter pylori infection, gastric inflammation and serum homocysteine concentration |
| Q36735639 | Correlation of oxidative stress parameters and inflammatory markers in tunisian coronary artery disease patients |
| Q36832379 | Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? |
| Q40622775 | Crosstalk between LXR and Toll-like Receptor Signaling Mediates Bacterial and Viral Antagonism of Cholesterol Metabolism |
| Q37877605 | De Novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model. |
| Q33503491 | Dental plaque, platelets, and cardiovascular diseases |
| Q33970537 | Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR |
| Q28345336 | Effect of Helicobacter pylori infection on blood pressure: a community based cross sectional study |
| Q37875878 | Effect of prior exposure to Chlamydia pneumoniae, Helicobacter pylori, or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction |
| Q55119080 | Effects of Helicobacter pylori eradication on serum lipid levels. |
| Q44479466 | Elevated concentrations of C-reactive protein in subjects with type 2 diabetes mellitus are moderately influenced by glycemic control |
| Q51466603 | Elevated homocysteine levels in patients with slow coronary flow: relationship with Helicobacter pylori infection. |
| Q30838023 | Epidemiological aspects of Helicobacter pylori infection in childhood and adolescence |
| Q33762140 | Epidemiology of Chlamydia pneumoniae in atherosclerosis |
| Q43967170 | Eradication of Helicobacter pylori infection induces an increase in body mass index |
| Q37880581 | Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction |
| Q77860878 | Evaluation of carotid arterial plaques after endarterectomy for Helicobacter pylori infection |
| Q43746630 | Extent of coronary atherosclerosis and homocysteine affect endothelial markers |
| Q33537924 | Extradigestive manifestations of Helicobacter pylori infection: fact and fiction |
| Q33401864 | Extragastrointestinal manifestations of Helicobacter pylori infection: facts or myth? A critical review |
| Q41658646 | For what conditions is there evidence-based justification for treatment of Helicobacter pylori infection? |
| Q45130861 | Further evidence of the association between periodontal conditions and coronary artery disease |
| Q24601951 | Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease |
| Q41548674 | Helicobacter Pylori Infection is Positively Associated with Metabolic Syndrome in Taiwanese Adults: a Cross-Sectional Study. |
| Q33762155 | Helicobacter and atherosclerosis |
| Q24683623 | Helicobacter pylori |
| Q41670268 | Helicobacter pylori Infection Increase the Risk of Myocardial Infarction: A Meta-Analysis of 26 Studies Involving more than 20,000 Participants |
| Q51024955 | Helicobacter pylori and cardiovascular complications: a mechanism based review on role of Helicobacter pylori in cardiovascular diseases. |
| Q37877726 | Helicobacter pylori and chronic bronchitis. |
| Q35592372 | Helicobacter pylori and coronary heart disease: which directions for future studies? |
| Q33760044 | Helicobacter pylori and extra-digestive diseases |
| Q41236976 | Helicobacter pylori and gastric cancer: an overrated risk? |
| Q28196450 | Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation |
| Q77180819 | Helicobacter pylori eradication ameliorates primary Raynaud's phenomenon |
| Q45009879 | Helicobacter pylori eradication decreases blood neutrophil and monocyte counts |
| Q92660845 | Helicobacter pylori eradication increases the serum high density lipoprotein cholesterol level in the infected patients with chronic gastritis: A single-center observational study |
| Q35011253 | Helicobacter pylori eradication lowers serum homocysteine level in patients without gastric atrophy |
| Q35289835 | Helicobacter pylori gastritis, a presequeale to coronary plaque |
| Q35580112 | Helicobacter pylori in intensive care: why we should be interested |
| Q73028058 | Helicobacter pylori infection |
| Q28365939 | Helicobacter pylori infection and fasting plasma glucose concentration |
| Q43611950 | Helicobacter pylori infection and migraine. |
| Q43727999 | Helicobacter pylori infection and the risk of acute coronary syndrome: a nationwide retrospective cohort study |
| Q43641878 | Helicobacter pylori infection as an independent risk factor for cerebral ischemia of atherothrombotic origin |
| Q92006171 | Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis: Focus in carotid artery plaque |
| Q46605193 | Helicobacter pylori infection does not accelerate the age-related progression of arteriosclerosis: a 4-year follow-up study |
| Q48320416 | Helicobacter pylori infection in subjects with acute ischaemic stroke |
| Q45282987 | Helicobacter pylori infection is not a correlate of plasma fibrinogen in the Australian population |
| Q35147488 | Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan. |
| Q36317666 | Helicobacter pylori infection: a risk factor for ischaemic cerebrovascular disease and carotid atheroma |
| Q34024709 | Helicobacter pylori is an aetiological factor for ischaemic heart disease: the case against |
| Q34024702 | Helicobacter pylori is an aetiological factor for ischaemic heart disease: the case in favour |
| Q44542686 | Helicobacter pylori serology in patients with angiographically documented coronary artery disease |
| Q40432710 | Helicobacter pylori seropositivity and atherosclerosis risk factors |
| Q33703897 | Helicobacter pylori seropositivity and cardiovascular risk factors in a multicultural workforce |
| Q81927315 | Helicobacter pylori seropositivity in patients with acute coronary syndromes |
| Q36836748 | Helicobacter pylori seropositivity in subjects with acute myocardial infarction |
| Q50892428 | Helicobacter pylori seropositivity is not associated with inflammatory parameters, lipid concentrations and degree of coronary artery disease. |
| Q34266402 | Helicobacter pylori-related diseases |
| Q33903977 | Helicobacter pylori. One bacterium and a broad spectrum of human disease! An overview. |
| Q44061290 | Helicobacter pylori: a new cardiovascular risk factor? |
| Q43018309 | Helicobacter pylori: the size of the problem |
| Q47832833 | Hematocrit and hemoglobin are independently related to insulin resistance and compensatory hyperinsulinemia in healthy, non-obese men and women |
| Q37851401 | High frequency of Chlamydophila pneumoniae infections: patients with peripheral arterial disease and those with risk factors for cardiovascular diseases compared to normal subjects |
| Q41341023 | Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease. |
| Q58230333 | Immune system activation follows inflammation in unstable angina: pathogenetic implications |
| Q42470753 | Immunization with bacillus Calmette-Guerin vaccine increases aortic atherosclerosis in the cholesterol-fed rabbit |
| Q30891408 | Increase of arterial thrombosis parameters in chronic Helicobacter pylori infection in mice. |
| Q43428266 | Infection and myocardial infarction |
| Q73575750 | Infection with virulent strains of Helicobacter pylori is not associated with ischaemic heart disease: evidence from a population-based case-control study of myocardial infarction |
| Q33540765 | Infection, immunisation and atherosclerosis: is there a link? |
| Q74464726 | Infection-associated intimal thickening in the coronary arteries of children |
| Q36368432 | Infectious agents are not necessary for murine atherogenesis |
| Q37092667 | Infectious causes of chronic inflammatory diseases and cancer |
| Q37874516 | Inflammation and infection in stable coronary disease and acute coronary syndrome |
| Q33829116 | Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? |
| Q35201247 | Inflammatory and thrombotic mechanisms in coronary atherosclerosis |
| Q37871076 | Inflammatory predictors of mortality in the Scandinavian Simvastatin Survival Study |
| Q89019414 | Influence of the Degree of Gastric Mucosal Atrophy on the Serum Lipid Levels Before and After the Eradication of Helicobacter pylori Infection |
| Q35863790 | Intestinal microbiota determine severity of myocardial infarction in rats |
| Q35145332 | Is periodontitis associated with an increased risk of coronary heart disease and preterm and/or low birth weight births? |
| Q61196180 | Is there an antigenic mimicry between arteriosclerotic lesions and H. pylori antigens? |
| Q73136940 | Is there an association between Helicobacter pylori infection and coronary heart disease? |
| Q37880514 | Is there an infective aetiology to atherosclerosis? |
| Q39570767 | Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. |
| Q30377539 | Long-term trends in cardiovascular disease mortality and association with respiratory disease. |
| Q33853043 | Markers of inflammation as predictors in cardiovascular disease |
| Q34204611 | Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. |
| Q37856198 | Microbial risk factors of cardiovascular and cerebrovascular diseases: potential therapeutical options |
| Q35159020 | Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation |
| Q54286866 | Molecular study of human herpesvirus 6 and 8 involvement in coronary atherosclerosis and coronary instability. |
| Q37869059 | Neopterin levels in patients with coronary artery disease are independent of Chlamydia pneumoniae seropositivity |
| Q63199394 | No Evidence of an Association betweenHelicobacter pyloriInfection and Raynaud Phenomenon |
| Q35722804 | No associations of Helicobacter pylori infection and gastric atrophy with plasma total homocysteine in Japanese |
| Q24804167 | Non-detection of Chlamydia species in carotid atheroma using generic primers by nested PCR in a population with a high prevalence of Chlamydia pneumoniae antibody |
| Q35504664 | Non-invasive testing for Helicobacter pylori |
| Q33820733 | Occupational exposure to dust: inflammation and ischaemic heart disease |
| Q77124527 | Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response |
| Q24673221 | Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs |
| Q40036082 | Periodontitis as a risk factor for cardiovascular disease: the role of anti-phosphorylcholine and anti-cardiolipin antibodies |
| Q36181163 | Persistent infection and vascular disease: a systematic review |
| Q42719518 | Phospholipid catabolism by gut microbiota and the risk of cardiovascular disease. |
| Q59710269 | Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease |
| Q57302791 | Polymorphisms in the TNF-alpha and TNF-receptor genes in patients with coronary artery disease |
| Q37871590 | Positive Chlamydia pneumoniae serology is associated with elevated levels of tumor necrosis factor alpha in patients with coronary heart disease |
| Q37869378 | Prevalence of Chlamydia pneumoniae in the atherosclerotic plaque of patients with unstable angina and its relation with serology |
| Q37391436 | Prevalence of Helicobacter pylori, cytomegalovirus, and Chlamydia pneumoniae immunoglobulin seropositivity in coronary artery disease patients and normal individuals in North Indian population |
| Q37873036 | Prevention of coronary heart disease through treatment of infection with Chlamydia pneumoniae? Estimation of possible effectiveness and costs. |
| Q34064191 | Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group |
| Q37041781 | Prognostic role of Helicobacter pylori infection in acute coronary syndrome: a prospective cohort study |
| Q36832346 | Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men |
| Q43840301 | Pulse-wave velocity and cardiovascular risk factors in subjects with Helicobacter pylori infection |
| Q37883934 | Rabbit model for Chlamydia pneumoniae infection |
| Q37882250 | Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group |
| Q43189191 | Relation of C reactive protein to cardiovascular risk factors. H pylori and C pneumoniae infections may account for most acute coronary syndromes |
| Q44357481 | Relation of C-reactive protein to features of the metabolic syndrome in normal glucose tolerant, impaired glucose tolerant, and newly diagnosed type 2 diabetic subjects |
| Q37878617 | Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study |
| Q45165754 | Relation of Helicobacter pylori infection and angiographically demonstrated coronary artery disease |
| Q36847941 | Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease |
| Q74176474 | Relations between Helicobacter pylori, thyroid disease and cardiovascular risk factors in a 56-65-year-old population |
| Q74269420 | Relationship between lipid peroxidation and plasma fibrinogen in middle-aged men |
| Q49192929 | Relationship between rheumatoid arthritis and periodontitis |
| Q34698619 | Review of evidence for a connection between Chlamydia pneumoniae and atherosclerotic disease |
| Q33776566 | Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies |
| Q27002402 | Role of Helicobacter pylori infection in pathogenesis of atherosclerosis |
| Q35374019 | Seasonal variations in out of hospital cardiopulmonary arrest |
| Q37877198 | Seropositivity to chlamydial lipopolysaccharide and Chlamydia pneumoniae, systemic inflammation and stable coronary artery disease: negative results of a case-control study |
| Q44186700 | Serum and mucosal cytokine profiles in patients with active Helicobacter pylori and ischemic heart disease: is there a relationship? |
| Q63363798 | Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma |
| Q34160606 | Should antibiotics now be part of routine treatment of coronary heart disease? |
| Q41313473 | Significance of Helicobacter pylori infection and gastric cancer: implications for screening. |
| Q35567077 | Significant association of cagA positive Helicobacter pylori strains with risk of premature myocardial infarction |
| Q35764383 | Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis |
| Q35558055 | Strong correlation between Helicobacter pylori seropositivity and Chlamydia pneumoniae IgG concentrations |
| Q46967741 | Study of arteriosclerosis in patients with hiatal hernia and reflux esophagitis |
| Q73515169 | Successful eradication of Helicobacter pylori as determined by ((13))C-urea breath test does not alter fibrinogen and acute phase response markers |
| Q33941972 | Systemic inflammation in cardiovascular and periodontal disease: comparative study |
| Q37875919 | T lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens. |
| Q89943833 | The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases |
| Q37205516 | The association between current Helicobacter pylori infection and coronary artery disease |
| Q57740621 | The association of chronic cough with the risk of myocardial infarction: the Framingham Heart Study |
| Q43159895 | The effect of different strains of Helicobacter pylori on platelet aggregation. |
| Q34348985 | The gut microbiota, environment and diseases of modern society |
| Q38122310 | The heart and the gut. |
| Q80814133 | The incidence of infectious diseases and changes in the mortality of atherosclerosis-related complications in the Czech population over the past two decades |
| Q33770472 | The possible role of infections in acute myocardial infarction |
| Q37879200 | The prevalence of Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic blood vessels of patients attending for redo and first time coronary artery bypass graft surgery |
| Q42390881 | The relation between Chlamydia pneumoniae and atherosclerosis |
| Q35085388 | The relation of C-reactive protein levels to total and cardiovascular mortality in older U.S. women |
| Q34557639 | The relationship between infection, inflammation, and cardiovascular disease: an overview |
| Q40409051 | The role of cytokines in unstable angina |
| Q34557697 | The role of inflammatory and immunological mediators in periodontitis and cardiovascular disease |
| Q34447107 | The role of risk factors in the development of atherosclerosis |
| Q54252809 | Updating the epidemiological transition model. |
| Q35962028 | Use of macrolides and tetracyclines for chronic inflammatory diseases |
| Q34011168 | Weighing the evidence for infection as a risk factor for coronary heart disease |
| Q41658639 | Who should be treated for Helicobacter pylori infection? A review of consensus conferences and guidelines. |
| Q73696395 | [Extradigestive manifestations of Helicobacter pylori infection. Science or fiction?] |
| Q57922203 | infection and liver diseases: Epidemiology and insights into pathogenesis |
Search more.